< 0 1 0 1 O
/=8 1 4 1 4 O
weeks 5 10 5 10 I-upper_bound
prior 11 16 11 16 I-upper_bound
to 17 19 17 19 O
screening 20 29 20 29 O

A 0 1 30 31 O
history 2 9 32 39 O
of 10 12 40 42 O
, 12 13 42 43 O
or 14 16 44 46 O
current 17 24 47 54 O
conditions 25 35 55 65 O
affecting 36 45 66 75 O
the 46 49 76 79 O
digestive 50 59 80 89 O
tract 60 65 90 95 O
, 65 66 95 96 O
such 67 71 97 101 O
as 72 74 102 104 O
ulcerative 75 85 105 115 B-chronic_disease
colitis 86 93 116 123 I-chronic_disease
, 93 94 123 124 O
indeterminate 95 108 125 138 B-chronic_disease
colitis 109 116 139 146 I-chronic_disease
, 116 117 146 147 O
fistulizing 118 129 148 159 B-chronic_disease
disease 130 137 160 167 I-chronic_disease
, 137 138 167 168 O
abdominal 139 148 169 178 B-chronic_disease
or 149 151 179 181 I-chronic_disease
perianal 152 160 182 190 I-chronic_disease
abscess 161 168 191 198 I-chronic_disease
, 168 169 198 199 O
adenomatous 170 181 200 211 B-chronic_disease
colonic 182 189 212 219 I-chronic_disease
polyps 190 196 220 226 I-chronic_disease
not 197 200 227 230 O
excised 201 208 231 238 O
, 208 209 238 239 O
colonic 210 217 240 247 B-chronic_disease
mucosal 218 225 248 255 I-chronic_disease
dysplasia 226 235 256 265 I-chronic_disease
, 235 236 265 266 O
and 237 240 267 270 O
short 241 246 271 276 B-chronic_disease
bowel 247 252 277 282 I-chronic_disease
syndrome 253 261 283 291 I-chronic_disease

Any 0 3 292 295 O
major 4 9 296 301 O
episode 10 17 302 309 O
of 18 20 310 312 O
infection 21 30 313 322 O
requiring 31 40 323 332 O
treatment 41 50 333 342 O
with 51 55 343 347 O
intravenous 56 67 348 359 B-treatment
antibiotics 68 79 360 371 I-treatment

Any 0 3 372 375 O
prior 4 9 376 381 B-treatment
treatment 10 19 382 391 I-treatment
with 20 24 392 396 I-treatment
anti 25 29 397 401 I-treatment
- 29 30 401 402 I-treatment
adhesion 30 38 402 410 I-treatment
molecules 39 48 411 420 I-treatment
( 49 50 421 422 O
e.g. 50 54 422 426 O
, 54 55 426 427 O
anti 56 60 428 432 B-treatment
- 60 61 432 433 I-treatment
mucosal 61 68 433 440 I-treatment
addressin 69 78 441 450 I-treatment
cell 79 83 451 455 I-treatment
adhesion 84 92 456 464 I-treatment
molecule 93 101 465 473 I-treatment
[ 102 103 474 475 I-treatment
anti 103 107 475 479 I-treatment
- 107 108 479 480 I-treatment
MAdCAM-1 108 116 480 488 I-treatment
] 116 117 488 489 I-treatment
) 117 118 489 490 O

Any 0 3 491 494 O
prior 4 9 495 500 B-treatment
treatment 10 19 501 510 I-treatment
with 20 24 511 515 I-treatment
ustekinumab 25 36 516 527 I-treatment
within 37 43 528 534 O
14 44 46 535 537 B-upper_bound
weeks 47 52 538 543 I-upper_bound
prior 53 58 544 549 I-upper_bound
to 59 61 550 552 O
randomization 62 75 553 566 O

Chronic 0 7 567 574 B-chronic_disease
hepatitis 8 17 575 584 I-chronic_disease
B 18 19 585 586 I-chronic_disease
or 20 22 587 589 I-chronic_disease
C 23 24 590 591 I-chronic_disease
infection 25 34 592 601 I-chronic_disease

Fistulas 0 8 602 610 B-chronic_disease
related 9 16 611 618 O
to 17 19 619 621 O
CD 20 22 622 624 B-chronic_disease

Has 0 3 625 628 O
received 4 12 629 637 O
non 13 16 638 641 O
- 16 17 641 642 O
permitted 17 26 642 651 O
inflammatory 27 39 652 664 B-treatment
bowel 40 45 665 670 I-treatment
disease 46 53 671 678 I-treatment
( 54 55 679 680 I-treatment
IBD 55 58 680 683 I-treatment
) 58 59 683 684 I-treatment
therapies 60 69 685 694 I-treatment
( 70 71 695 696 O
including 71 80 696 705 O
natalizumab 81 92 706 717 B-treatment
, 92 93 717 718 O
vedolizumab 94 105 719 730 B-treatment
, 105 106 730 731 O
and 107 110 732 735 O
efalizumab 111 121 736 746 B-treatment
, 121 122 746 747 O
as 123 125 748 750 O
stated 126 132 751 757 O
in 133 135 758 760 O
the 136 139 761 764 O
protocol 140 148 765 773 O
) 148 149 773 774 O

Ileostomy 0 9 775 784 B-treatment
or 10 12 785 787 O
colostomy 13 22 788 797 B-treatment

Intolerance 0 11 798 809 O
, 11 12 809 810 O
refractory 13 23 811 821 B-chronic_disease
disease 24 31 822 829 I-chronic_disease

Moderately 0 10 830 840 O
to 11 13 841 843 O
severely 14 22 844 852 O
active 23 29 853 859 O
CD 30 32 860 862 B-chronic_disease
as 33 35 863 865 O
determined 36 46 866 876 O
by 47 49 877 879 O
the 50 53 880 883 O
CDAI 54 58 884 888 B-treatment

Planned 0 7 889 896 O
surgery 8 15 897 904 B-treatment
for 16 19 905 908 O
CD 20 22 909 911 O

Treatment 0 9 912 921 B-treatment
with 10 14 922 926 I-treatment
antibiotics 15 26 927 938 I-treatment
as 27 29 939 941 I-treatment
adjunctive 30 40 942 952 I-treatment
therapy 41 48 953 960 I-treatment
for 49 52 961 964 O
CD 53 55 965 967 B-chronic_disease
in 56 58 968 970 O
the 59 62 971 974 O
absence 63 70 975 982 O
of 71 73 983 985 O
documented 74 84 986 996 O
infection 85 94 997 1006 B-chronic_disease

Use 0 3 1007 1010 B-contraception_consent
of 4 6 1011 1013 I-contraception_consent
effective 7 16 1014 1023 I-contraception_consent
contraception 17 30 1024 1037 I-contraception_consent
as 31 33 1038 1040 O
defined 34 41 1041 1048 O
by 42 44 1049 1051 O
the 45 48 1052 1055 O
protocol 49 57 1056 1064 O

active 0 6 1065 1071 O
or 7 9 1072 1074 O
latent 10 16 1075 1081 B-chronic_disease
tuberculosis 17 29 1082 1094 I-chronic_disease
( 30 31 1095 1096 O
participants 31 43 1096 1108 O
with 44 48 1109 1113 O
prior 49 54 1114 1119 O
history 55 62 1120 1127 O
of 63 65 1128 1130 O
Bacillus 66 74 1131 1139 B-treatment
Calmette 75 83 1140 1148 I-treatment
- 83 84 1148 1149 I-treatment
Guérin 84 90 1149 1155 I-treatment
[ 91 92 1156 1157 I-treatment
BCG 92 95 1157 1160 I-treatment
] 95 96 1160 1161 I-treatment
vaccination 97 108 1162 1173 I-treatment
must 109 113 1174 1178 O
pass 114 118 1179 1183 O
protocol 119 127 1184 1192 O
- 127 128 1192 1193 O
defined 128 135 1193 1200 O
screening 136 145 1201 1210 O
criteria 146 154 1211 1219 O
) 154 155 1219 1220 O

anti 0 4 1221 1225 B-treatment
- 4 5 1225 1226 I-treatment
TNF 5 8 1226 1229 I-treatment
therapy 9 16 1230 1237 I-treatment
within 17 23 1238 1244 O
5 24 25 1245 1246 B-upper_bound
years 26 31 1247 1252 I-upper_bound
from 32 36 1253 1257 O
screening 37 46 1258 1267 O

human 0 5 1268 1273 B-chronic_disease
immunodeficiency 6 22 1274 1290 I-chronic_disease
virus 23 28 1291 1296 I-chronic_disease
( 29 30 1297 1298 I-chronic_disease
HIV 30 33 1298 1301 I-chronic_disease
) 33 34 1301 1302 I-chronic_disease

intolerance 0 11 1303 1314 O
to 12 14 1315 1317 O
one 15 18 1318 1321 O
or 19 21 1322 1324 O
more 22 26 1325 1329 O
anti 27 31 1330 1334 B-allergy_name
- 31 32 1334 1335 I-allergy_name
TNF 32 35 1335 1338 I-allergy_name
therapies 36 45 1339 1348 I-allergy_name
are 46 49 1349 1352 O
eligible 50 58 1353 1361 O
to 59 61 1362 1364 O
participate 62 73 1365 1376 O
in 74 76 1377 1379 O
the 77 80 1380 1383 O
study 81 86 1384 1389 O
provided 87 95 1390 1398 O
they 96 100 1399 1403 O
are 101 104 1404 1407 O
intolerant 105 115 1408 1418 O
or 116 118 1419 1421 O
refractory 119 129 1422 1432 O
to 130 132 1433 1435 O
CS 133 135 1436 1438 B-allergy_name
or 136 138 1439 1441 O
IS 139 141 1442 1444 B-allergy_name
therapy 142 149 1445 1452 I-allergy_name

oral 0 4 1453 1457 B-clinical_variable
antibiotics 5 16 1458 1469 I-clinical_variable
< 17 18 1470 1471 O
/=4 18 21 1471 1474 O
weeks 22 27 1475 1480 I-upper_bound
prior 28 33 1481 1486 I-upper_bound
to 34 36 1487 1489 O
screening 37 46 1490 1499 O

